Evommune (EVMN) EVP reports 5,074-share tax withholding, holds 67,794 shares

Rhea-AI Filing Summary

Evommune, Inc. executive vice president of operations reported an insider equity transaction. On 12/09/2025, the officer had 5,074 shares of Evommune common stock withheld, coded as an "F" transaction, at a price of $17.84 per share. The filing explains these shares were withheld to satisfy tax withholding obligations tied to the settlement of restricted stock units, rather than being an open-market sale. After this tax-related transaction, the reporting person beneficially owned 67,794 shares of Evommune common stock directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Drew Janice Suzann

Role EVP, Operations

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock	5,074	$17.84	$91K

Holdings After Transaction: Common Stock — 67,794 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Drew Janice Suzann

(Last) (First) (Middle)

C/O EVOMMUNE, INC.

1841 PAGE MILL ROAD, SUITE 100

(Street)

PALO ALTO CA 94304

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Evommune, Inc. [ EVMN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Operations

3. Date of Earliest Transaction (Month/Day/Year)
12/09/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/09/2025		F		5,074(1)	D	$17.84	67,794	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares were withheld to satisfy the Reporting Person's tax withholding obligations in connection with the settlement of restricted stock units.

Remarks:

	/s/ Gregory S. Moss, Attorney-in-Fact	12/11/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Evommune (EVMN) report in this Form 4?

The filing reports that an Evommune executive vice president of operations had 5,074 shares of common stock withheld on 12/09/2025 to cover tax obligations related to restricted stock units.

What is the transaction code used in the Evommune (EVMN) Form 4 filing?

The transaction is coded as "F", which indicates shares were disposed of to pay the reporting person’s tax withholding obligations in connection with equity compensation.

At what price were the Evommune (EVMN) shares withheld for tax purposes?

The 5,074 shares of Evommune common stock were withheld at a price of $17.84 per share to satisfy tax withholding obligations.

How many Evommune (EVMN) shares does the insider own after this transaction?

Following the reported transaction, the insider beneficially owned 67,794 shares of Evommune common stock in direct ownership.

What was the reason given for the Evommune (EVMN) share withholding?

The filing explains that the 5,074 shares were withheld to satisfy the reporting person’s tax withholding obligations in connection with the settlement of restricted stock units.

What is the insider’s role at Evommune (EVMN) in this Form 4?

The reporting person is identified as an officer of Evommune, serving as EVP, Operations.